Outcomes 2016 - Baylor Hamilton Heart and Vascular Hospital FY 2016 | Page 40

FY16 Team:
• James W. Choi, MD, FACC, FSCAI
• Paul A. Grayburn, MD, FACC
• Robert F. Hebeler, Jr. MD, FACS
• Albert C. Henry, III, MD, FACS
• Brian Lima, MD
• Juan MacHannaford, MD
• Robert C. Stoler, MD, FACC, FSCAI
TRANSCATHETER AORTIC VALVE
REPLACEMENT CASES
138 115
performed in
FY16
performed
in FY15
• Ravi C. Vallabhan, MD, FACC, FSCAI
• Melanie Miller Durham, MS, RN, ANP-BC, APRN, CEPS
• Laney Solsberry, MSN, CCRN-CSC
• Paz McDonald, BSN, CCRN, RN-BC
• Clinical Research Coordinators
Specialized interventions include:
• Transcatheter Aortic Valve Replacement (TAVR)
– Medtronic Evolut™ R
– Medtronic Evolut ™ R 34 mm Valve
– Sapien S3 Valve
– LOTUS™ Valve (research) COMMERCIAL TAVR
• Transcatheter Mitral Valve Repair
– MitraClip®
– Tendyne TMVR device (research)
– Intrepid TMVR (research) FY16:
• Transcatheter pulmonic valve replacement (with Sapien)
• Minimally invasive aortic valve replacement and mitral valve
repair and replacement using sternal sparing, port-access
approaches
Since TAVR started at Baylor Hamilton Heart and
Vascular Hospital:
300
400
TH
EARLY
FY17:
TH
TAVR
celebrated
TAVR will be
celebrated
• Other TAVR, TMVR options available through
research studies
Interventional cardiologists on the medical staff at Baylor
Hamilton Heart and Vascular Hospital were called to
international locations to help proctor and share best practices
throughout fiscal year 2016.
Patients with Hypertrophic Obstructive Cardiomyopathy
(HOCM) have also been treated using alcohol septal ablation.
HOCM is a rare but often fatal heart condition. Cardiologists
on the medical staff have long-standing experience for patients
with HOCM.
38
*NCDR FY16
Severe aortic stenosis occurs when the aortic valve
does not open or close properly forcing the heart
to work harder to pump blood through the body.
Approximately 500,000 of aortic stenosis patients
are considered severe cases with half presenting
symptoms. Research shows that left untreated,
severe aortic stenosis has a 50 percent mortality
rate at two years.